The first validation batch of Sputnik V coronavirus vaccine produced in Minsk is to undergo quality control and compliance assessment. It was bottled at the Belmedpreparaty company using Russian technology at one of the best production lines with the latest equipment. After compliance assessment, production on an industrial scale will be launched. It is planned that Belmedpreparaty will fully meet the country's need for the vaccine. The pharmaceutical company plans to produce 500 thousand doses per month. In the future, Belarus will be able not only to produce Sputnik V, but also to export the vaccine to third countries.